Towards personalized lung cancer CT screening in Europe

C. Van der Aalst (Rotterdam, Netherlands), M. Oudkerk (Groningen, Netherlands), K. Ten Haaf (Rotterdam, Netherlands), D. Baldwin (Nottingham, United Kingdom), R. Murray (Nottingham, United Kingdom), E. O'Dowd (Nottingham, United Kingdom), R. Kaaks (Heidelberg, Germany), V. Katzke (Heidelberg, Germany), N. Becker (Heidelberg, Germany), J. Espinàs (Barcelona, Spain), J. Borras (Barcelona, Spain), C. Aigner (Essen, Germany), C. Balleyguier (Paris, France), D. Planchard (Paris, France), S. Janes (London, United Kingdom), G. Sozzi (Milan, Italy), U. Pastorino (Milan, Italy), H. De Koning (Rotterdam, Netherlands)

Source: Virtual Congress 2020 – Screening and imaging in lung cancer
Session: Screening and imaging in lung cancer
Session type: Oral Presentation
Number: 4171

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Van der Aalst (Rotterdam, Netherlands), M. Oudkerk (Groningen, Netherlands), K. Ten Haaf (Rotterdam, Netherlands), D. Baldwin (Nottingham, United Kingdom), R. Murray (Nottingham, United Kingdom), E. O'Dowd (Nottingham, United Kingdom), R. Kaaks (Heidelberg, Germany), V. Katzke (Heidelberg, Germany), N. Becker (Heidelberg, Germany), J. Espinàs (Barcelona, Spain), J. Borras (Barcelona, Spain), C. Aigner (Essen, Germany), C. Balleyguier (Paris, France), D. Planchard (Paris, France), S. Janes (London, United Kingdom), G. Sozzi (Milan, Italy), U. Pastorino (Milan, Italy), H. De Koning (Rotterdam, Netherlands). Towards personalized lung cancer CT screening in Europe. 4171

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Cost-effectiveness of lung cancer screening with CT-scan
Source: Virtual Congress 2020 – Frontiers of lung cancer screening
Year: 2020


Factors determining early adherence to a lung cancer screening protocol
Source: Eur Respir J 2007; 30: 532-537
Year: 2007



The evidence on CT: lung cancer screening
Source: ERS Research Seminar 2018 – Lung Cancer Screening: from Trial to Practice
Year: 2018

Update on lung cancer screening with low-dose CT
Source: Virtual Congress 2021 – Highlights from the JAMA Network on idiopathic pulmonary fibrosis, chronic obstructive pulmonary disease and lung cancer screening
Year: 2021


Screening for lung cancer
Source: ISSN=1025-448x, ISBN=1-904097-18-9, page=71
Year: 2001

The ALA/ATS implementation guide on lung cancer screening
Source: International Congress 2018 – Imminent global problems in lung cancer require joint action: time for an international alliance!
Year: 2018


Study to assess the utility of head CT in the staging of lung cancer in the post-PET era
Source: Annual Congress 2009 - Epidemiology and management of lung cancer
Year: 2009


The clinical benefit of personalised medicine in lung cancer
Source: International Congress 2014 – Understanding the benefit of current personalised medicine platforms
Year: 2014



Prevalence of COPD in a lung cancer screening programme with low dose CT scan
Source: Annual Congress 2009 - Clinical aspects and epidemiology in lung cancer
Year: 2009

Screening of lung cancer: imaging modalities
Source: Annual Congress 2009 - PG2 Core Curriculum Postgraduate Course: Lung cancer imaging: case and problem based
Year: 2009



Management of lung cancer screening and incidental findings as well as their integration in existing lung cancer care
Source: International Congress 2019 – PG1 Lung cancer: the key multidisciplinary approach
Year: 2019


Lung function predicts lung cancer risk in smokers: a tool for targeting screening programmes
Source: Eur Respir J 2010; 35: 146-151
Year: 2010



Missed lung cancer on chest radiography – does it affect the outcome?
Source: Annual Congress 2007 - Diagnosis and staging of lung cancer: existing and new techniques
Year: 2007



Proportion of incident lung cancers that would have been eligible for a lung cancer screening program in Australia
Source: Virtual Congress 2021 – Screening, diagnosis, management and prognosis of lung cancer
Year: 2021


An abnormal CT, now what: issues in the diagnosis and management of a patient with a potential lung cancer
Source: Annual Congress 2006 - MP11 - An abnormal CT, now what: issues in the diagnosis and management of a patient with a potential lung cancer
Year: 2006

What the radiologist can offer - the latest imaging and evaluation techniques for lung cancer screening and comorbidities
Source: International Congress 2018 – Lung cancer screening and management of solitary pulmonary nodules
Year: 2018


The proportion of lung cancer patients attending UK lung cancer clinics who would have been eligible for low-dose CT screening
Source: Eur Respir J, 54 (2) 1802221; 10.1183/13993003.02221-2018
Year: 2019



Implementation of lung cancer screening in Europe: the way forward
Source: Virtual Congress 2020 – Thoracic oncology
Year: 2020